VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
On Mar. 27, 2020, University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19…
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced a collaboration to accelerate the…
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
On Mar. 26, 2020, Dynavax and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a collaboration supporting the…
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…